Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer. (Q46055974)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813359%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813359%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813359%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

William P Harris

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813359%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

J Thaddeus Beck

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813359%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Boris A Berdov

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813359%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Stephanie A Wagner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813359%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Eduard M Pshevlotsky

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813359%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Sergei A Tjulandin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813359%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Oleg A Gladkov

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813359%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Randall F Holcombe

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813359%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Ronald Korn

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813359%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Natarajan Raghunand

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813359%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Samuel Dychter

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813359%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Ping Jiang

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813359%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

H Michael Shepard

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813359%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Craig E Devoe

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813359%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

English

0 references

publication date

26 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813359%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

published in

Clinical Cancer Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813359%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813359%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813359%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

2848-2854

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813359%20AND%20SRC:MED&resulttype=core&format=json

Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).

6 March 2020

cites work

1 reference

12 December 2020

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

12 December 2020

Molecules involved in mammalian sperm-egg interaction

1 reference

12 December 2020

The impact of extracellular matrix on the chemoresistance of solid tumors--experimental and clinical results of hyaluronidase as additive to cytostatic chemotherapy.

1 reference

12 December 2020

Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival

1 reference

12 December 2020

Pancreatic cancer and thromboembolic disease.

1 reference

12 December 2020

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

1 reference

12 December 2020

Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal models

1 reference

12 December 2020

Pooled survival and response data from phase III randomized controlled trials for gemcitabine-based regimes in the treatment of advanced pancreatic cancer

1 reference

12 December 2020

Automated registration of sequential breath-hold dynamic contrast-enhanced MR images: a comparison of three techniques

1 reference

12 December 2020

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

1 reference

12 December 2020

Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer

1 reference

12 December 2020

Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma

1 reference

12 December 2020

Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer

1 reference

12 December 2020

Effective targeting of the tumor microenvironment for cancer therapy.

1 reference

12 December 2020

Modeling and predicting clinical efficacy for drugs targeting the tumor milieu

1 reference

12 December 2020

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

1 reference

12 December 2020

Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis

1 reference

12 December 2020

Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States

1 reference

12 December 2020

A Bayesian meta-analysis of multiple treatment comparisons of systemic regimens for advanced pancreatic cancer

1 reference

12 December 2020

Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer

1 reference

12 December 2020

Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial

1 reference

12 December 2020

10.1158/1078-0432.CCR-15-2010

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813359%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference